Verapamil and acute dystonia

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 1, 1998, Pages 79-80

  Pina, M A ^a   Ara, J R ^b,c   Remirez A ^a   Castiella, J ^a  

^a HOSPITAL OBISPO POLANCO   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; VERAPAMIL;

ADULT; ARTICLE; CASE REPORT; DYSTONIA; FEMALE; HEART PALPITATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA;

ADULT; ANTI-ARRHYTHMIA AGENTS; DIAZEPAM; DYSTONIA; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MUSCLE RELAXANTS, CENTRAL; TACHYCARDIA, SUPRAVENTRICULAR; VERAPAMIL;

EID: 0031873587     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Padrell MD, Navarro M, Faura CC, Horga JE (1995) Verapamil induced parkinsonism. American Journal of Medicine, 99, 436.
2. Helmuth D, Ljaljevic Z, Ramirez, L, Meltzer HY. (1989) Choreoathetosis induced by verapamil and lithium treatment. Journal of Clinical Psychopharmacology, 9, 454-455.
3. Hicks BC, Abraham K. (1985) Verapamil and myoclonic dystonia. Annals of Internal Medicine, 103, 154.
4. Abad V, Ovsiew F. (1993) Treatment of persistent myoclonic tardive dystonia with verapamil. British Journal of Psychiatry, 162, 554-556.
5. Kelley SR, Kamal TJ, Molitch ME. (1996) Mechanism of verapamil calcium channel blockade induced hyperprolactinemia. American Journal of Physiology, 270, 96-100.